Literature DB >> 35213372

Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study.

Heidi I L Jacobs1,2,3,4, Adrienne O'Donnell5,6, Claudia L Satizabal6,7,8, Cristina Lois1,2,4, Daniel Kojis5,6, Bernard J Hanseeuw1,4,9, Emma Thibault1,4, Justin S Sanchez1,4, Rachel F Buckley1,2,10, Qiong Yang5, Charles DeCarli11, Ron Killiany7, Muralidharan Sargurupremraj8, Reisa A Sperling1,2,12, Keith A Johnson1,2,4,12, Alexa S Beiser5,6,7, Sudha Seshadri6,7,8.   

Abstract

The brainstem is among the first regions to accumulate Alzheimer's disease (AD)-related hyperphosphorylated tau pathology during aging. We aimed to examine associations between brainstem volume and neocortical amyloid-β or tau pathology in 271 middle-aged clinically normal individuals of the Framingham Heart Study who underwent MRI and PET imaging. Lower volume of the medulla, pons, or midbrain was associated with greater neocortical amyloid burden. No associations were detected between brainstem volumes and tau deposition. Our results support the hypothesis that lower brainstem volumes are associated with initial AD-related processes and may signal preclinical AD pathology.

Entities:  

Keywords:  Aging; amyloid; brainstem; tau

Mesh:

Substances:

Year:  2022        PMID: 35213372      PMCID: PMC9038711          DOI: 10.3233/JAD-215372

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.160


  35 in total

1.  Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network.

Authors:  Aurélie Bussy; B Joy Snider; Dean Coble; Chengjie Xiong; Anne M Fagan; Carlos Cruchaga; Tammie L S Benzinger; Brian A Gordon; Jason Hassenstab; Randall J Bateman; John C Morris
Journal:  Neurobiol Aging       Date:  2018-10-13       Impact factor: 4.673

2.  Cortical surface-based analysis. I. Segmentation and surface reconstruction.

Authors:  A M Dale; B Fischl; M I Sereno
Journal:  Neuroimage       Date:  1999-02       Impact factor: 6.556

3.  CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.

Authors:  Anders M Fjell; Kristine B Walhovd; Christine Fennema-Notestine; Linda K McEvoy; Donald J Hagler; Dominic Holland; James B Brewer; Anders M Dale
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

4.  Relationship between APOE Genotype and Structural MRI Measures throughout Adulthood in the Study of Health in Pomerania Population-Based Cohort.

Authors:  M Habes; J B Toledo; S M Resnick; J Doshi; S Van der Auwera; G Erus; D Janowitz; K Hegenscheid; G Homuth; H Völzke; W Hoffmann; H J Grabe; C Davatzikos
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-12       Impact factor: 3.825

5.  The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology.

Authors:  U Rüb; K Del Tredici; C Schultz; D R Thal; E Braak; H Braak
Journal:  Acta Neuropathol       Date:  2001-06       Impact factor: 17.088

6.  Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data.

Authors:  Douglas N Greve; Claus Svarer; Patrick M Fisher; Ling Feng; Adam E Hansen; William Baare; Bruce Rosen; Bruce Fischl; Gitte M Knudsen
Journal:  Neuroimage       Date:  2013-12-19       Impact factor: 6.556

7.  Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology.

Authors:  Connie W Tsao; Ramachandran S Vasan
Journal:  Int J Epidemiol       Date:  2015-12       Impact factor: 7.196

8.  Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.

Authors:  Marta Marquié; Marc D Normandin; Charles R Vanderburg; Isabel M Costantino; Elizabeth A Bien; Lisa G Rycyna; William E Klunk; Chester A Mathis; Milos D Ikonomovic; Manik L Debnath; Neil Vasdev; Bradford C Dickerson; Stephen N Gomperts; John H Growdon; Keith A Johnson; Matthew P Frosch; Bradley T Hyman; Teresa Gómez-Isla
Journal:  Ann Neurol       Date:  2015-09-25       Impact factor: 10.422

9.  Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease.

Authors:  Robin de Flores; Laura E M Wisse; Sandhitsu R Das; Long Xie; Corey T McMillan; John Q Trojanowski; John L Robinson; Murray Grossman; Edward Lee; David J Irwin; Paul A Yushkevich; David A Wolk
Journal:  Alzheimers Dement       Date:  2020-04-22       Impact factor: 21.566

10.  Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals.

Authors:  Heidi I L Jacobs; Trey Hedden; Aaron P Schultz; Jorge Sepulcre; Rodrigo D Perea; Rebecca E Amariglio; Kathryn V Papp; Dorene M Rentz; Reisa A Sperling; Keith A Johnson
Journal:  Nat Neurosci       Date:  2018-02-05       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.